OKITA, R., SHIMIZU, K., NOJIMA, Y., YUKAWA, T., MAEDA, A., SAISHO, S., & NAKATA, M. (2015). Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells. Oncol Rep.
Chicago Stili AlıntıOKITA, RIKI, KATSUHIKO SHIMIZU, YUJI NOJIMA, TAKURO YUKAWA, AI MAEDA, SHINSUKE SAISHO, ve MASAO NAKATA. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.
MLA AlıntıOKITA, RIKI, et al. "Lapatinib Enhances Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Via Upregulation of HER2 in Malignant Mesothelioma Cells." Oncol Rep 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..